Unlock stock picks and a broker-level newsfeed that powers Wall Street.
KOSDAQ - Delayed Quote KRW

Ray Co., Ltd. (228670.KQ)

Compare
7,930.00
-10.00
(-0.13%)
At close: April 4 at 3:30:30 PM GMT+9
Loading Chart for 228670.KQ
  • Previous Close 7,940.00
  • Open 7,620.00
  • Bid 7,960.00 x --
  • Ask 8,030.00 x --
  • Day's Range 7,620.00 - 8,250.00
  • 52 Week Range 5,070.00 - 16,440.00
  • Volume 72,263
  • Avg. Volume 144,349
  • Market Cap (intraday) 122.878B
  • Beta (5Y Monthly) 0.98
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 22,700.00

RAY Co., Ltd. provides x-ray diagnostic equipment in the dental industry. The company offers RAYSACN Series, RAYios, RAYFace, RAYDENT Microscan, RIO Series, RAYDENT designer and tray, RAYSmiler, RAYDENT Studio, and RAYDENT Mill 4X and 5X, as well as consumables. RAY Co., Ltd. was incorporated in 2004 and is headquartered in Seongnam-si, South Korea.

www.raymedical.co.kr

214

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 228670.KQ

View More

Performance Overview: 228670.KQ

Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is KOSPI Composite Index (^KS11) .

YTD Return

228670.KQ
36.25%
KOSPI Composite Index (^KS11)
2.75%

1-Year Return

228670.KQ
53.35%
KOSPI Composite Index (^KS11)
10.09%

3-Year Return

228670.KQ
69.08%
KOSPI Composite Index (^KS11)
10.61%

5-Year Return

228670.KQ
49.17%
KOSPI Composite Index (^KS11)
42.89%

Compare To: 228670.KQ

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 228670.KQ

View More

Valuation Measures

Annual
As of 4/4/2025
  • Market Cap

    122.88B

  • Enterprise Value

    180.65B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.55

  • Price/Book (mrq)

    1.68

  • Enterprise Value/Revenue

    2.26

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -3.11%

  • Return on Assets (ttm)

    0.91%

  • Return on Equity (ttm)

    -4.44%

  • Revenue (ttm)

    143.23B

  • Net Income Avi to Common (ttm)

    -4.45B

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    36.96B

  • Total Debt/Equity (mrq)

    74.92%

  • Levered Free Cash Flow (ttm)

    -36.75B

Research Analysis: 228670.KQ

View More

Company Insights: 228670.KQ

Research Reports: 228670.KQ

View More

People Also Watch